Combivir · DIN 02239213 · 150 mg & 300 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.Discontinued December 31, 2024 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-12-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Combivir · DIN 02239213
Manufacturer: ViiV Healthcare ULC; listing date 1999-09-15
Health Canada: Cancelled post market since 2024-12-31 · brand COMBIVIR · ATC J05AR01 ZIDOVUDINE AND LAMIVUDINE · form Tablet · route Oral · ingredients LAMIVUDINE 150 MG, ZIDOVUDINE 300 MG · company Viiv healthcare ulc · schedule Prescription
Ministry pays: $2.6103 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02239213)
Source record
DIN 02239213: Combivir
Raw flags: sec3=Y
Item: 081800049; group id 95; item number 0167; lccId None; manufacturer id VIH
Source form: Tab; strength: 150mg & 300mg
Recorded listing: General benefit
Source prices (unrounded): $13.2262; ministry $2.6103
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02239213
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=62673
Interchangeable products
Apo-Lamivudine-Zidovudine · DIN 02375540 · $2.6103
Auro-Lamivudine/Zidovudine · DIN 02414414 · $2.6103
Jamp Lamivudine / Zidovudine · DIN 02502801 · $2.6103
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since December 31, 2024 — choose a marketed DIN from the same-category list.